Fig. 2From: Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemiaGraft-versus-host disease (GVHD) and GVHD-free, relapse-free survival (GRFS)Back to article page